Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges
Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. | Fortschritte der Neurologie-Psychiatrie | 2 August 2017
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes
Brown, T. K., & Alper, K. | The American Journal of Drug and Alcohol Abuse | 25 May 2017
Ayahuasca Modifies Amphetamine Self Ingestion and Modifies Anxiety and Locomotor Activity in Adolescent Rats
Godinho, A. F., Silva, M. C., & Kawashima, J. D. | Electronic J Biol | 9 May 2017
A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents
Vargas‐Perez, H., Grieder, T. E., Ting‐A‐Kee, R., Maal‐Bared, G., Chwalek, M., & van der Kooy, D. | European Journal of Neuroscience | 4 May 2017
Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report
Wilkins, C., dos Santos, R. G., Solá, J., Aixalá, M., Cura, P., Moreno, E., ... & Bouso, J. C. | Journal of Psychedelic Studies | 28 April 2017
A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial
McAndrew, A., Lawn, W., Stevens, T., Porffy, L., Brandner, B., & Morgan, C. J. | Trials | 4 April 2017
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
Johnson, M. W., Garcia-Romeu, A., Johnson, P. S., & Griffiths, R. R. | Journal of Psychopharmacology | 18 January 2017
Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences
Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017
Conducting Qualitative Research With Psychedelic Psychopharmacologists: Challenges of Co-Production in an Era of Interdisciplinarity
Noorani, T. | Sage Research Method Cases | 3 March 2017
The association of psychedelic use and opioid use disorders among illicit users in the United States
Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. | Journal of Psychopharmacology | 14 February 2017
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017
Clinical potential of psilocybin as a treatment for mental health conditions
Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017
Treating drug dependence with the aid of ibogaine: A qualitative study
Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017
Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?
Sessa, B. | Journal of Psychedelic Studies | 30 December 2016
The antiaddictive effects of ibogaine: A systematic literature review of human studies
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016
A One-Dose Psychedelic Fix for Addiction?
Jacobson, R. | Scientific American Mind | 8 December 2016
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration
Aarde, S. M., & Taffe, M. A. | Current Topics in Behavorial Neuroscience | 2 December 2016
Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase
Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016
The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens
Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016
Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use
Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016
Psychedelics as Medicines: An emerging new paradigm
Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016
Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism
Bogenschutz, M. P., & Forcehimes, A. A. | Journal of Humanistic Psychology | 16 October 2016
The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment
Skocylas, R. | UBC Medical Journal | 1 September 2016
Psilocybin for treating substance use disorders?
de Veen, B. T., Schellekens, A. F., Verheij, M. M., & Homberg, J. R. | Expert Review of Neurotherapeutics | 12 August 2016
Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study
Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016